🎧 Behind the Breakthroughs
Step into the minds shaping the future of medicine.
Listen on your preferred platform:
Apple → https://t.co/mHHfEvcLPF
Spotify → https://t.co/xwS0ZZQ143
IPM → https://t.co/L7YbogYq8F
#PrecisionMedicine#BehindTheBreakthroughs#MedTech#Biotech
New PET Imaging Changes Care in Clear Cell Kidney Cancer
CAIX-targeted PET imaging improves detection and staging of clear cell kidney cancer, with potential applications in personalized treatment
@sbuedutr#kidneycancer#PETimaging#clinicalcare
https://t.co/Ylf30ubBE2
Some Assistive Reproductive Technology May Raise Childhood Cancer Risk
Frozen embryo transfer and intracytoplasmic sperm injection could increase risk of childhood cancer in those exposed to the technology
#DanishCancerInstitute#IVF#pediatriconcology
https://t.co/ZkexrNwkg8
From Nobel to Nasdaq: Financing Nordic Precision Medicine’s Next Step
Europe has world-class #biotech research, but can it scale? @NLSDays explores the capital, expertise, and regulatory reforms needed to turn discovery into patient impact
#healthcare
https://t.co/j8tT3kTxSN
Worlds Apart: Genomics Experts Still Split on Newborn Sequencing Guidelines
The 2026 ICoNS conference revealed major disagreements over testing, disclosure, and genetic information use for newborn care
@GrinsteinJ#genomics#neonatalscreening#raredisease
https://t.co/5r4fUmbXbO
Blood Test Identifies Residual Cancer
Microscopic traces of cancer in the bloodstream can identify patients who are high risk of their cancer returning, research suggests
@nyulangone#biomarkers#hematologictests#NSCLC#lungcancer#ctDNA
https://t.co/tpO1l7S0uu
With In Vivo 'Gene Writers,' Tessera Shows DNA Engineering Differentiation
The all-RNA #genomeengineering platform can permanently insert therapeutic genes and generate functional #CARTcells in vivo, addressing “copycat” criticism
@TesseraTx#geneediting
https://t.co/Kr28qweThv
Targeted Brain Ultrasound Could Help Relieve Schizophrenia Symptoms
Low-intensity targeted #ultrasound could be an effective treatment for delusions in people with #schizophrenia or schizoaffective disorder
@ShohamLab@nyugrossman#Alzheimersdisease
https://t.co/Tg9cGBWMhi
New Molecular Target for Treating Type 2 Diabetes Identified
Targeting the mitochondrial protein Miro1 could offer a new approach to treating insulin resistance in type 2 diabetes
@LSU@NIH@BrownUniversity#diabetes#insulinresistance#mitochondria
https://t.co/hxQ9Pyw4k4
IMU Biosciences and UK Biobank to Create Large Immune Dataset
The U.K. biotech IMU Biosciences will help create a large and detailed immune dataset for 80,000 people in the @uk_biobank@WatersCorp@UltimaGenomics#biobanks#immunecells#omics
https://t.co/z2wSWZUGLx
Early Drivers of Autoimmune Kidney Damage Identified, Opening Door to Targeted Treatment
New research reveals how autoimmune kidney inflammation develops and identifies an antibody-based strategy that may prevent lasting damage
@UOsaka_en#genetics#omics
https://t.co/mBob1TM1x9
GLP-1 Drugs Linked to Fewer Heart Complications and Infections After Surgery
GLP-1 medications may reduce complications after surgery, with new research linking their use to fewer cardiovascular events and infections
@UTHealthHouston#diabetes#GLP1
https://t.co/aHZueChMMV
Breast Cancer Treatment Response Predictors Revealed Through Multi-Omics Analysis
Researchers use #multiomics and spatial profiling to identify potential #biomarkers of treatment response and resistance in breast cancer
@FudanUniversity#breastcancer
https://t.co/c8eMftQAZK
Magnetic Millirobots Could Deliver Cancer Drugs Directly to Hard-to-Reach Tumors
A modular robotic system uses magnetic guidance to deliver drugs precisely, with potential applications in oncology
@JohnsHopkins#anticancerdrugs#AI#drugdelivery
https://t.co/uJI250ly9X
Trapping ecDNA in Micronuclei Improves Cancer Patient Survival
Trapping extrachromosomal (ec)DNA in micronuclei during cell division weakens aggressive cancers with high levels of ecDNA in their cells
@anton_gh@ChariteBerlin#DNAdamage#cancertherapy
https://t.co/d9HjCRbQcW
Whole-Genome Diagnostics Evolve with RNA and Pangenome Integration
@AmbryGenetics' GenomeNext test uncovers rare diseases with more comprehensive sequencing, diverse genomic references, and ongoing reanalysis
#genetictesting#WGS#DNA#rarediseases
https://t.co/kh2cNiUnfN
ADPKD Gene Therapy Development at Newly Launched Estuary Biotherapeutics
As one of the world’s most common genetic diseases, developing treatments for ADPKD is both a daunting and important task
#EstuaryBiotherapeutics#genetherapy#kidneydiseases#ADPKD
https://t.co/LLCLw0oSQV